Abbvie Inc. (ABBV) — 8-K Filings

8-K Filings (29)

• AbbVie Inc. Files 8-K: Operations & Financials Update — Apr 29, 2026 Risk: low
  AbbVie Inc. filed an 8-K report on April 29, 2026, detailing its results of operations and financial condition. The filing includes financial statements and exh
• AbbVie Inc. Files 8-K on Financials — Oct 31, 2025 Risk: low
  AbbVie Inc. filed an 8-K on October 31, 2025, reporting on its financial condition and results of operations. The filing also includes financial statements and
• AbbVie Inc. Files 8-K on Financials and Debt — Oct 3, 2025 Risk: low
  On October 3, 2025, AbbVie Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various seni
• AbbVie Inc. Files 8-K Report — Sep 11, 2025 Risk: low
  On September 11, 2025, AbbVie Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with a Regulation FD disclosure.
• AbbVie Inc. Files 8-K on Financial Operations — Jul 31, 2025 Risk: low
  On July 31, 2025, AbbVie Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various senior
• AbbVie Inc. Files 8-K on Financials and Senior Notes — Jul 3, 2025 Risk: low
  On July 3, 2025, AbbVie Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various senior
• AbbVie Inc. Files 8-K: Director Changes and Shareholder Votes — May 13, 2025 Risk: low
  On May 8, 2025, AbbVie Inc. filed an 8-K report detailing several key events. The filing includes information regarding the departure and election of directors,
• AbbVie Inc. Files 8-K on Financials — Apr 25, 2025 Risk: low
  AbbVie Inc. filed an 8-K on April 25, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibit
• AbbVie Inc. Files 8-K on Financial Operations — Apr 3, 2025 Risk: low
  On April 3, 2025, AbbVie Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various senior
• AbbVie Inc. Files 8-K Report — Feb 26, 2025 Risk: low
  On February 26, 2025, AbbVie Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financi
• AbbVie Inc. Files 8-K: Senior Notes and Stock Details — Feb 19, 2025 Risk: low
  On February 18, 2025, AbbVie Inc. filed an 8-K report detailing other events and financial statements. The filing includes information about its common stock an
• AbbVie Inc. Files 8-K on Officer Changes and Financials — Feb 14, 2025 Risk: low
  AbbVie Inc. filed an 8-K on February 14, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain office
• AbbVie Inc. Files 8-K Report — Feb 5, 2025 Risk: low
  On January 30, 2025, AbbVie Inc. filed an 8-K report detailing "Other Events." The filing does not contain specific financial transactions or material events be
• AbbVie Inc. Files 8-K on Financials and Debt — Jan 31, 2025 Risk: low
  On January 31, 2025, AbbVie Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various sen
• AbbVie Inc. Discloses Material Impairment — Jan 10, 2025 Risk: medium
  On January 9, 2025, AbbVie Inc. filed an 8-K report indicating a material impairment. The filing does not specify the exact amount of the impairment or the asse
• AbbVie Inc. Files 8-K on Financial Operations — Jan 6, 2025 Risk: low
  On January 6, 2025, AbbVie Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various seni
• AbbVie Inc. Files 8-K: Director and Officer Changes — Dec 13, 2024 Risk: low
  On December 11, 2024, AbbVie Inc. (ABBV) filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the de
• AbbVie Inc. Files 8-K on Financials and Senior Notes — Oct 30, 2024 Risk: low
  On October 30, 2024, AbbVie Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various sen
• AbbVie Files 8-K on Financials and Senior Notes — Oct 3, 2024 Risk: low
  On October 3, 2024, AbbVie Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various seni
• AbbVie Inc. Files Routine 8-K Report — Sep 10, 2024 Risk: low
  On September 6, 2024, AbbVie Inc. filed an 8-K report detailing amendments to its articles of incorporation or bylaws and financial statements. The filing does
• AbbVie Inc. Files 8-K on Financial Operations — Jul 25, 2024 Risk: low
  On July 25, 2024, AbbVie Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various senior
• AbbVie Inc. Files 8-K on Financials and Senior Notes — Jul 3, 2024 Risk: low
  On July 3, 2024, AbbVie Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various senior
• AbbVie Files 8-K on Financials and Debt — Apr 26, 2024 Risk: low
  AbbVie Inc. filed an 8-K on April 26, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibit
• AbbVie Inc. Files 8-K on Financial Operations — Apr 3, 2024 Risk: low
  On April 3, 2024, AbbVie Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various senior
• AbbVie Details Senior Notes in Latest 8-K Filing — Feb 26, 2024 Risk: low
  AbbVie Inc. filed an 8-K on February 26, 2024, reporting on "Other Events" and "Financial Statements and Exhibits" as of February 22, 2024. The filing details v
• AbbVie 8-K Details Officer Changes, Compensation, and Debt Structure — Feb 20, 2024 Risk: low
  AbbVie Inc. filed an 8-K on February 20, 2024, reporting on events that occurred on February 14, 2024. The filing details information regarding the departure or
• AbbVie 8-K: Rule 425 Filing Signals Potential Transaction — Feb 12, 2024 Risk: medium
  AbbVie Inc. filed an 8-K on February 12, 2024, primarily to satisfy filing obligations under Rule 425 of the Securities Act, indicating written communications r
• AbbVie 8-K Details Financial Condition, Senior Notes on Feb 2 — Feb 2, 2024
  AbbVie Inc. filed an 8-K on February 2, 2024, reporting on its results of operations and financial condition. This filing indicates that AbbVie is providing upd
• AbbVie Updates on Financial Condition, Senior Notes Maturities — Jan 5, 2024
  AbbVie Inc. filed an 8-K on January 5, 2024, to report on its financial condition and results of operations. This filing specifically mentions various senior no

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX